Industry Viewpoints: The potential impact of Brexit on UK clinical research by Nathan Nagel. Macro environmental market forces are always changing and the BREXIT means significant PESTLE changes to the UK LifeScience and healthcare ecosystems. However, I use the word ‘change’ not end, as the nation’s competitiveness depends on the capacity of its backbone industries to adapt to change through innovation. So what should the UK do after BREXIT, the obvious but easy option is to focus on what a Switzerland-like deal would mean, with Britain obtaining associated country status. Read more